Lund's Halmos Labs raises $500K seed, joins Y Combinator
What's the deal? Halmos LabsDealroom has a profile for this one. Try Dealroom →, a biotech startup based in Lund, Sweden, has raised $500,000 in seed funding and joined Y Combinator's fall 2026 batch, which led the round.
What's the endgame? The company builds automated biotech R&D on the principles of validity and interpretability. It runs research and simulations to answer questions ranging from wetlab experiment design to full cancer vaccine manufacturing.
What's next? While the company is named Halmos Labs, its first product will be called Halmos BioDealroom has a profile for this one. Try Dealroom →, founder Mattias Akke told Swedish Tech News, which first reported the news.
Founders Akke and Linus von Ekensteen Löfgren have backgrounds in nanotechnology and engineering physics, plus experience at MIT, AstraZenecaDealroom has a profile for this one. Try Dealroom →, and Danske BankDealroom has a profile for this one. Try Dealroom →.
The signal: The $500,000 round sits toward the lower end of seed deals by size, typical of a Y Combinator entry, where the accelerator's cheque and network often matter more than the headline figure at this stage.
Read more: oresundstartups.com
Image credit: europeanspaceagency
